Posts

Showing posts with the label Clostridium Difficile Infection Treatment Market Share

Clostridium Difficile Infection Treatment Market Excellent Growth 2021 Top Key Players

Image
  Clostridium difficile, which produces gram-positive bacterium, is definitely an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or could be caused due to healthcare associated infection with clinical manifestation including asymptomatic infection to watery diarrhea or serious intestinal condition such as colitis and colonic perforation. This infection could be diagnosed by enzyme immunoassays for toxins or Clostridium difficile glutamate dehydrogenase (GDH) and nucleic acid amplification tests for Clostridium difficile toxin genes or endoscopy. Limited forms of drugs such as metronidazole, fidoxamycin and vancomycin are merely readily available for the treatment of Clostridium difficile infection. In case there is any severe pain or toxic megacolon in abdominal wall, patients undergo surgery for removal of infected portion. Upsurge in the usage of antibiotics and easy availability ...